Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3208)
All Articles published online
|
Jan 28, 2011 (publication date) through Feb 11, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Trapero-Marugán M, Mendoza J, Chaparro M, González-Moreno L, Moreno-Monteagudo JA, Borque MJ, Moreno-Otero R. Long-term outcome of chronic hepatitis C patients with sustained virological response to peginterferon plus ribavirin. World J Gastroenterol 2011; 17(4): 493-498 [PMID: 21274379 DOI: 10.3748/wjg.v17.i4.493] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i4/493.htm |
| Number | Citing Articles |
| 1 |
Adriaan J. van der Meer, Jordan J. Feld, Harald Hofer, Piero L. Almasio, Vincenza Calvaruso, Conrado M. Fernández-Rodríguez, Soo Aleman, Nathalie Ganne-Carrié, Roberta D’Ambrosio, Stanislas Pol, Maria Trapero-Marugan, Raoel Maan, Ricardo Moreno-Otero, Vincent Mallet, Rolf Hultcrantz, Ola Weiland, Karoline Rutter, Vito Di Marco, Sonia Alonso, Savino Bruno, Massimo Colombo, Robert J. de Knegt, Bart J. Veldt, Bettina E. Hansen, Harry L.A. Janssen. Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication. Journal of Hepatology 2017; 66(3): 485 doi: 10.1016/j.jhep.2016.10.017
|
| 2 |
Vasilios Papastergiou, Maria Stampori, Phillipos Lisgos, Crisostomos Pselas, Kleopatra Prodromidou, Stylianos Karatapanis. Durability of a sustained virological response, late clinical sequelae, and long-term changes in aspartate aminotransferase to the platelet ratio index after successful treatment with peginterferon/ribavirin for chronic hepatitis C. European Journal of Gastroenterology & Hepatology 2013; 25(7): 798 doi: 10.1097/MEG.0b013e32835eb8bf
|
| 3 |
Fanpu Ji, Zhifang Cai, Hong Deng. Comment on: “Effect of sustained virologic response on the incidence of hepatocellular carcinoma in patients with HCV cirrhosis”. The Brazilian Journal of Infectious Diseases 2011; 15(4): 410 doi: 10.1016/S1413-8670(11)70219-7
|
| 4 |
Sabela Lens, Xavier Forns. Utilidad de la elastografía de transición tras la respuesta virológica en la hepatitis crónica por el virus de la hepatitisC. Enfermedades Infecciosas y Microbiología Clínica 2013; 31(7): 421 doi: 10.1016/j.eimc.2013.04.008
|
| 5 |
Patricia Cordero-Ruiz, Isabel Carmona-Soria, Manuel Rodríguez-Téllez, Angel Caunedo-Alvarez, Roberto H. Quezada-Pacheco, Alexander Flores-Cucho, Manuel Romero-Gómez, Ángel Vilches-Arenas. Long-term follow-up of patients with chronic hepatitis C treated with α-interferon and ribavirin antiviral therapy: clinical and fibrosis impact of treatment response. European Journal of Gastroenterology & Hepatology 2017; 29(7): 792 doi: 10.1097/MEG.0000000000000886
|
| 6 |
X. Wang, F. Gao, G. Yuan, K. Shi, Y. Huang, Y. Chen, R. Qiu, L. Sun, J. Liu, C. Hu, Y. Zhou. Ten‐year follow‐up analysis of chronic hepatitis C patients after getting sustained virological response to pegylated interferon‐α and ribavirin therapy. Journal of Viral Hepatitis 2016; 23(12): 971 doi: 10.1111/jvh.12574
|
| 7 |
M. Trapero-Marugán, R. Moreno-Otero. Tratamiento de las hepatitis virales. Medicine - Programa de Formación Médica Continuada Acreditado 2011; 10(92): 6249 doi: 10.1016/S0304-5412(11)70250-5
|
| 8 |
Bryony Simmons, Jawaad Saleem, Andrew Hill, Richard D. Riley, Graham S. Cooke. Risk of Late Relapse or Reinfection With Hepatitis C Virus After Achieving a Sustained Virological Response: A Systematic Review and Meta-analysis. Clinical Infectious Diseases 2016; 62(6): 683 doi: 10.1093/cid/civ948
|
| 9 |
Raymond Odhiambo, Jagpreet Chhatwal, Shannon Allen Ferrante, Antoine El Khoury, Elamin Elbasha. Economic Evaluation of Boceprevir for the Treatment of Patients with Genotype 1 Chronic Hepatitis C Virus Infection in Hungary. Journal of Health Economics and Outcomes Research 2013; 1(1): 62 doi: 10.36469/9854
|
| 10 |
G. Lutchman, N. H. Nguyen, C. Y. Chang, A. Ahmed, T. Daugherty, G. Garcia, R. Kumari, S. Gupta, D. Doshi, M. H. Nguyen. Effectiveness and tolerability of simeprevir and sofosbuvir in nontransplant and post‐liver transplant patients with hepatitis C genotype 1. Alimentary Pharmacology & Therapeutics 2016; 44(7): 738 doi: 10.1111/apt.13761
|
| 11 |
Ya Wen, Yi Xiang Zheng, De Ming Tan. A Comprehensive Long-Term Prognosis of Chronic Hepatitis C Patients With Antiviral Therapy; A Meta-Analysis of Studies From 2008 to 2014. Hepatitis Monthly 2015; 15(5) doi: 10.5812/hepatmon.15(5)2015.27181
|
| 12 |
|
| 13 |
Faleh Z. Alfaleh, Khalid Alswat, Ahmed Helmy, Waleed Al‐hamoudi, Mohamed El‐sharkawy, Mohanned Omar, Ahmed Shalaby, Mohaned A. Bedewi, Qais Hadad, Safiyya M. Ali, Ahmad Alfaleh, Ayman A. Abdo. The natural history and long‐term outcomes in patients with chronic hepatitis C genotype 4 after interferon‐based therapy. Liver International 2013; 33(6): 871 doi: 10.1111/liv.12127
|
| 14 |
Vivian Ng, Sammy Saab. Effects of a Sustained Virologic Response on Outcomes of Patients With Chronic Hepatitis C. Clinical Gastroenterology and Hepatology 2011; 9(11): 923 doi: 10.1016/j.cgh.2011.05.028
|
| 15 |
Jeong Heo. Durability of antiviral therapy for chronic hepatitis C after achieving sustained virological response. The Korean Journal of Hepatology 2011; 17(3): 180 doi: 10.3350/kjhep.2011.17.3.180
|
| 16 |
K. Rutter, A. F. Stättermayer, S. Beinhardt, T.-M. Scherzer, P. Steindl-Munda, M. Trauner, P. Ferenci, H. Hofer. Successful anti-viral treatment improves survival of patients with advanced liver disease due to chronic hepatitis C. Alimentary Pharmacology & Therapeutics 2015; 41(6): 521 doi: 10.1111/apt.13085
|
| 17 |
Victoria Belousova, Ahmed A. Abd-Rabou, Shaker A. Mousa. Recent advances and future directions in the management of hepatitis C infections. Pharmacology & Therapeutics 2015; 145: 92 doi: 10.1016/j.pharmthera.2014.09.002
|
| 18 |
Shelagh M. Szabo, Jennifer C. Samp, David R. Walker, Suzanne Lane, Stephanie K. Cline, Katherine L. Gooch, Ricardo Jimenez-Mendez, Adrian R. Levy. Liver-specific case fatality due to chronic hepatitis C virus infection: A systematic review. Annals of Hepatology 2015; 14(5): 618 doi: 10.1016/S1665-2681(19)30756-2
|